Advertisement

Prevalence of Mucopolysaccharidosis Types I, II, and VI in the Pediatric and Adult Population with Carpal Tunnel Syndrome (CTS). Retrospective and Prospective Analysis of Patients Treated for CTS

  • Mette Borch NørmarkEmail author
  • Nanna Kjaer
  • Allan Meldgaard Lund
Research Report
Part of the JIMD Reports book series (JIMD, volume 36)

Abstract

Background: We wanted to investigate whether the prevalence of mucopolysaccharidoses (MPS) I, II, and VI was higher than expected in a selected cohort of patients with carpal tunnel syndrome (CTS). CTS is a common finding in patients with MPS, and therefore we screened patients who had undergone surgery for CTS for undiagnosed MPS.

Patients and Methods: Patients who had been operated for CTS were found in databases from two hospitals. Furthermore, patients who had undergone surgery for CTS when under the age of 18 were retrieved from the National Patient Registry. All included patients had a filter paper blood spot sample taken that was subsequently analyzed enzymatically for MPS I, II, and VI.

Results: 425 patients were included. 402 patients tested negative in the first test. 23 had inconclusive result whereof 18 was negative in a second test. The remaining five patients had two inconclusive tests each and were referred for further examination at the Center for Inherited Metabolic Diseases where the diagnosis was excluded. Thus, all included patients were negative for both MPS I, II and VI.

Discussion/Conclusion: Though our sample size is relatively small, results indicate that MPS is not prevalent in a cohort of adult patients with monosymptomatic CTS, and that screening is not indicated in this setting.

Keywords

Carpal tunnel syndrome High-risk screening MPS Mucopolysaccharidosis Screening 

References

  1. al-Qattan MM, Thomson HG, Clarke HM (1996) Carpal tunnel syndrome in children and adolescents with no history of Trauma. J Hand Surg Br 21(1):108–111CrossRefPubMedGoogle Scholar
  2. Atroshi I et al (2011) Incidence of physician-diagnosed carpal tunnel syndrome in the general population. Arch Intern Med 171(10):941–954. doi: 10.1001/archinternmed.2011.203 CrossRefGoogle Scholar
  3. Beck M et al (2007) Mucopolysaccharidoses: a guide for physicians and parents, vol 2007 (Uni-Med Science, n.d.)Google Scholar
  4. Cobos PN et al (2014) Dried blood spots allow targeted screening to diagnose Mucopolysaccharidosis and Mucolipidosis. JIMD Rep 15:123–132. doi: 10.1007/8904_2014_308 PubMedPubMedCentralGoogle Scholar
  5. Coelho JC et al (1997) Selective screening of 10,000 high-risk Brazilian patients for the detection of inborn errors of metabolism. Eur J Pediatr 156(8):650–654. doi: 10.1007/s004310050685 CrossRefPubMedGoogle Scholar
  6. Davis L, Vedanarayanan VV (2014) Carpal tunnel syndrome in children. Pediatr Neurol 50(1):57–59CrossRefPubMedGoogle Scholar
  7. Haddad FS et al (1997) Carpal tunnel syndrome in the Mucopolysaccharidoses and Mucolipidoses. J Bone Joint Surg Br 79(4):576–582CrossRefPubMedGoogle Scholar
  8. Katz JN, Simmons BP (2002) Clinical practice. Carpal tunnel syndrome. N Engl J Med 346(23):1807–1812CrossRefPubMedGoogle Scholar
  9. Lukacs Z (2013) High-risk population screening for Mucopolysaccharidoses and pompe disease [abstract]. Mol Genet Metab 108(2):62CrossRefGoogle Scholar
  10. Lukacs Z, Santer R, Nieves P (2014) Target-population screening for lysosomal disorders—a highly efficient tool for the diagnosis of patients [abstract]. Mol Genet Metab 111(2):S72–S73CrossRefGoogle Scholar
  11. Ly-Pen D, Andreu J, de Blas G, Sanchez-Olaso A, Jiménez San-Emeterio J (2010) Prevalence of Mucopolyisaccharidosis I in a pediatric and young adult population diagnosed with carpal tunnel syndrome [abstract]. Ann Rheum Dis 69(suppl 3):113Google Scholar
  12. Gunilla Malm et al., ‘Mucopolysaccharidoses in the Scandinavian Countries: incidence and prevalence’, Acta Paediatr 97, no. 11 (November 2008): 1577–1581.Google Scholar
  13. Mendelsohn NJ et al (2010) Importance of surgical history in diagnosing Mucopolysaccharidosis Type II (Hunter syndrome): data from the Hunter outcome survey. Genet Med 12(12):816–822. doi: 10.1097/GIM.0b013e3181f6e74d CrossRefPubMedGoogle Scholar
  14. Potulska-Chromik A et al (2014) Carpal tunnel syndrome in children. J Child Neurol 29(2):227–231CrossRefPubMedGoogle Scholar
  15. Thomas JA et al (2010) Childhood onset of scheie syndrome, the attenuated form of Mucopolysaccharidosis I. J Inherit Metab Dis 33(4):421–427CrossRefPubMedPubMedCentralGoogle Scholar
  16. Van Meir N, De Smet L (2005) Carpal tunnel syndrome in children. J Pediatr Orthop B 14(1):42–45CrossRefPubMedGoogle Scholar
  17. Wang S, Hou J, Lin J (2006) A retrospective epidemiological and etiological study of metabolic disorders in children with cardiomyopathies. Acta Paediatr Taiwan 47(2):83–87PubMedGoogle Scholar

Copyright information

© SSIEM and Springer-Verlag Berlin Heidelberg 2017

Authors and Affiliations

  • Mette Borch Nørmark
    • 1
    Email author
  • Nanna Kjaer
    • 2
  • Allan Meldgaard Lund
    • 3
  1. 1.Department of NeurosurgeryCopenhagen University HospitalCopenhagenDenmark
  2. 2.Faculty of Health and SciencesCopenhagen UniversityCopenhagenDenmark
  3. 3.Center for Inherited Metabolic Diseases, Department of Clinical GeneticsCopenhagen University HospitalCopenhagenDenmark

Personalised recommendations